Abstract:The performance of small-diameter vascular grafts adapted to vascular replacement is commonly hin-dered by stenosis. To address this issue, a graft featuring rapid remodeling with degradation is war-ranted. In this work, a 1.8-mm-diameter graft was constructed by fabricating a decellularized human amniotic membrane (HAM) with polycaprolactone (PCL)/silk fibroin (SF) around it through electrospin-ning, namely, an HPS graft, and applied in a rat aortic grafting model for comparison to a decellularized porcine small intestinal submucosa (SIS)-integrated PCL/SF (SPS) graft and an autologous aorta. In vitro studies demonstrated that HAM provided a bioactive milieu for rapid endothelial cell proliferation and re-sisting fibroblast-induced collagen secretion. PCL/SF provides a biocompatible microenvironment for cel-lular infiltration with mechanical properties resembling those of the rat aorta. In vivo studies showed that the HPS graft induced functional endothelialization more rapidly, along with less intensive ECM deposi-tion than the SPS graft upon the histologically weaker inflammatory response and foreign body reaction 4 weeks after implantation, and maintained patency by progressively stabilizing the remodeling structure approximating the native counterparts over 24 weeks. The bioengineered graft expands the applicability of allogeneic matrices with degradable electrospun polymers for long-term in situ vascular applications.Statement of significanceAn orchestrated remodeling of the vascular graft, featuring rapid endothelialization and resisting extracel-lular matrix (ECM) deposition on the luminal surface, with a mechanically stable structure, is requisite for long-term vascular patency. Nevertheless, off-the-shelf grafts might not fulfil the criteria under abdom-inal aortic pressure. Herein, we fabricated a 1.8-mm-diameter vascular graft through the integration of a decellularized human amniotic membrane (HAM) with electrospun polycaprolactone (PCL)/silk fibroin (SF). In a rat aortic grafting model, the graft is capable of rapid endothelialization and resisting collagen deposition and provides a native-like mechanical structure for stabilizing the remodeling process towards that of the native aorta. This bioengineered graft has potential for small-diameter vascular regeneration, and provides advanced strategies to facilitate full-remodeling tissue applications.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

dECM based dusal-responsive vascular graft with enzyme-controlled adenine release for long-term patency

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Construction of Tissue-Engineered Vascular Grafts with Enhanced Patency by Integrating Heparin, Cell-Adhesive Peptide, and Carbon Monoxide Nanogenerators into Acellular Blood Vessels

Biomimetic Niche of Vascular Intima with Biophysical Orientation and Biochemical Stimulation for Rapid Endothelialization and Long-Term Patency

Engineered Vascular Graft Using Nanoscale Decellularized Arteries Modified with Controlled-Release Heparin and Vascular Endothelial Growth Factor

Construction of Enzyme-Laden Vascular Scaffolds Based on Hyaluronic Acid Oligosaccharides-Modified Collagen Nanofibers for Antithrombosis and In-Situ Endothelialization of Tissue-Engineered Blood Vessels.

Biologically responsive, long-term release nanocoating on an electrospun scaffold for vascular endothelialization and anticoagulation

A bioactive compliant vascular graft modulates macrophage polarization and maintains patency with robust vascular remodeling

Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization

Co-immobilization of ACH11 Antithrombotic Peptide and CAG Cell-Adhesive Peptide Onto Vascular Grafts for Improved Hemocompatibility and Endothelialization.

Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H<sub>2</sub>S for Anti-Inflammation and Anticalcification

Development of a Decellularized Human Amniotic Membrane-Based Electrospun Vascular Graft Capable of Rapid Remodeling for Small-Diameter Vascular Applications.

Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H2S for Anti-Inflammation and Anticalcification

Bilayer Vascular Grafts with On-Demand NO and H2S Release Capabilities.

Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug

Regulation of Macrophage Polarization and Promotion of Endothelialization by NO Generating and PEG-YIGSR Modified Vascular Graft.

Functionalization of in Vivo Tissue-Engineered Living Biotubes Enhance Patency and Endothelization Without the Requirement of Systemic Anticoagulant Administration.

A chitosan modified asymmetric small-diameter vascular graft with anti-thrombotic and anti-bacterial functions for vascular tissue engineering.

Amelioration of Blood Compatibility and Endothelialization of Polycaprolactone Substrates by Surface-Initiated Atom Transfer Radical Polymerization

Biomimetic Vascular Grafts with Circumferentially and Axially Oriented Microporous Structures for Native Blood Vessel Regeneration

Biodegradable and Elastomeric Vascular Grafts Enable Vascular Remodeling